SCHEMBL522662

SCHEMBL522662

CC(=O)[C@](N)(CCCCN)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ODC1 P11926 2/20 0.42
PAOX Q6QHF9 3/20 0.40
LMNA P02545 3/20 0.40
BLM P54132 3/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
PMP22 Q01453 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP2D6 P10635 1/20 0.38
NFKB1 P19838 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
THRB P10828 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
PLG P00747 1/20 0.37
ALOX15 P16050 1/20 0.37
SLC6A2 P23975 1/20 0.37
RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL522663 1.00 ODC1 (0.42) ODC1PAOXLMNABLMKDM4E
Hydrochloric Acid SCHEMBL8205380 0.98 BLM (0.43) ODC1PAOXLMNABLMKDM4E
Hydrochloric Acid SCHEMBL8205379 0.98 BLM (0.43) ODC1PAOXLMNABLMKDM4E
SCHEMBL3744397 0.94 ODC1 (0.48) ODC1PAOXLMNABLMKDM4E
SCHEMBL3744393 0.94 ODC1 (0.48) ODC1PAOXLMNABLMKDM4E
SCHEMBL3627363 0.94 ODC1 (0.48) ODC1PAOXLMNABLMKDM4E
SCHEMBL9617305 0.89 PAOX (0.44) ODC1PAOXLMNABLMKDM4E
SCHEMBL449961 0.87 PAOX (0.48) ODC1PAOXLMNABLMCYP2D6
SCHEMBL2115160 0.87 ODC1 (0.48) ODC1PAOXLMNABLMKDM4E
SCHEMBL20636765 0.85 ODC1 (0.38) ODC1PAOXLMNABLMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118688315-A Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds 复旦大学 2024-09-24 CN claimed
EP-0723552-B1 OLIGOPEPTIDES DERIVED FROM C-REACTIVE PROTEIN FRAGMENTS ITALFARMACO SPA (IT) 2002-10-23 EP claimed
US-6342481-B1 RESIDUES OF THREONINE, LEUCINE, ISOLEUCINE, VALINE, SARCOSINE, ALANINE, GLYCINE AND ACYLGLYCINE ITALFARMACO S.P.A. (IT) 2002-01-29 US claimed
CN-120158266-A Easily-cleaned organic silicon temporary bonding material and preparation method and application thereof 深圳市化讯半导体材料有限公司 2025-06-17 CN disclosed
CN-118858500-B Method for detecting metabolites of triangular bream fertilized eggs in different developmental stages 浙江省农业科学院 2025-02-07 CN disclosed
US-20250020656-A1 EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS AJINOMOTO CO., INC. (JP) 2025-01-16 US disclosed
CN-118858500-A Method for detecting metabolites of triangular bream fertilized eggs in different developmental stages 浙江省农业科学院 2024-10-29 CN disclosed
WO-2024206366-A2 GENETICALLY ENCODED SYSTEM FOR QUANTIFYING RUBISCO ACTIVITY IN CATALYZING CARBON FIXATION THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-03 WO disclosed
CN-118688315-A Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds 复旦大学 2024-09-24 CN disclosed
CN-117740961-A Compound analysis method of liquorice and liquorice probiotics fermentation preparation 北京中医药大学 2024-03-22 CN disclosed
US-11835499-B2 Methods of quantifying methylglyoxal-induced nucleic acid adducts CITY OF HOPE (US) 2023-12-05 US disclosed
EP-2421883-A1 TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES Eisai R&D Management Co., Ltd. (JP) 2012-02-29 EP disclosed
US-20120028284-A1 TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-02-02 US disclosed
WO-2010123085-A1 TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES EISAI R & D MANAGEMENT CO., LTD. (JP) 2010-10-28 WO disclosed
WO-2010122673-A1 TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-10-28 WO disclosed
US-20100102218-A1 METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG CITY OF HOPE 2010-04-29 US disclosed
US-20070105092-A1 Proteolytic and covalent antibodies COVALENT BIOSCIENCE INCORPORATED 2007-05-10 US disclosed
EP-1615946-A2 PROTEOLYTIC AND COVALENT ANTIBODIES The University of Texas (US) 2006-01-18 EP disclosed
WO-2004087735-A2 PROTEOLYTIC AND COVALENT ANTIBODIES THE UNIVERSITY OF TEXAS (US) 2004-10-14 WO disclosed
WO-1998010292-A1 MONOCLONAL ANTIBODIES SPECIFIC FOR PROSTATE SPECIFIC ANTIGEN AND METHODS OF DETECTING PROSTATE SPECIFIC ANTIGEN CENTOCOR, INC. (US) 1998-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028284-A1 TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES CYP11B1, CYP11B2, CYP1A1 ODC1 2284/4885PAOX 183/4885LMNA 1435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.